Renal insufficiency
Chronic renal failure (CRF) refers to a slowly progressive renal impairment caused by various kidney diseases, which eventually leads to uremia and complete loss of renal function, causing a series of clinical symptoms and a clinical syndrome consisting of biochemical, endocrine and other metabolic disorders. The interval from the onset of the primary disease to the onset of renal insufficiency can be several years to more than ten years. Chronic renal failure is a serious stage of renal insufficiency.
-
Site of disease:
kidney -
Infectious :
Not contagious -
Frequent population:
All groups -
Related symptoms:
Hyperuric acid metabolism lethargy sleepiness blood pressure drop chronic renal insufficiency -
Concurrent disease:
Related Drugs
Carvedilol
Indication: It is an α and β receptor blocker. It has a vasodilating effect while blocking the receptors. It is used to treat mild and moderate hypertension or hypertension patients with renal insufficiency and diabetes.
Manufacturer:
Hainan Bikai Pharmaceutical Co., Ltd.
Carvedilol
Indication: It is an α and β receptor blocker. It has a vasodilating effect while blocking the receptors. It is used to treat mild and moderate hypertension or hypertension patients with renal insufficiency and diabetes.
Manufacturer:
Zhuhai Free Trade Zone Lizhu Synthetic Pharmaceutical Co., Ltd.
Carvedilol
Indication: It is an α and β receptor blocker. It has a vasodilating effect while blocking the receptors. It is used to treat mild and moderate hypertension or hypertension patients with renal insufficiency and diabetes.
Recombinant human erythropoietin injection (CHO cells)
Indication: 1. Anemia caused by renal insufficiency, including dialysis and non-dialysis patients. 2. Red blood cell mobilization during perioperative period of surgery. 3. Anemia caused by chemotherapy in the treatment of non-bone malignant tumors. It is not used to treat anemia caused by other factors (such as iron or folate deficiency, hemolysis or gastrointestinal bleeding) in cancer patients.
Manufacturer:
Shanxi Weiqidaguangming Pharmaceutical Co., Ltd.
Allopurinol
Indication: 1. Primary and secondary hyperuricemia, especially hyperuricemia caused by excessive uric acid production; 2. Patients with recurrent or chronic gout; 3. Tophi; 4. Uric acid kidney stones and/or uric acid nephropathy; 5. Hyperuricemia with renal insufficiency.
Manufacturer:
China Resources Double-Crane Pharmaceutical Co., Ltd.
Allopurinol
Indication: 1. Primary and secondary hyperuricemia, especially hyperuricemia caused by excessive uric acid production; 2. Patients with recurrent or chronic gout; 3. Tophi; 4. Uric acid kidney stones and/or uric acid nephropathy; 5. Hyperuricemia with renal insufficiency.
Manufacturer:
Beijing Taiyang Pharmaceutical Industry Co., Ltd.
Allopurinol
Indication: 1. Primary and secondary hyperuricemia, especially hyperuricemia caused by excessive uric acid production; 2. Patients with recurrent or chronic gout; 3. Tophi; 4. Uric acid kidney stones and/or uric acid nephropathy; 5. Hyperuricemia with renal insufficiency.
Manufacturer:
Wuxi Taxus Pharmaceutical Co., Ltd.
Allopurinol
Indication: 1. Primary and secondary hyperuricemia, especially hyperuricemia caused by excessive uric acid production; 2. Patients with recurrent or chronic gout; 3. Tophi; 4. Uric acid kidney stones and/or uric acid nephropathy; 5. Hyperuricemia with renal insufficiency.
Manufacturer:
Chongqing Qingyang Pharmaceutical Co., Ltd.
Allopurinol Tablets
Indication: 1. Primary and secondary hyperuricemia, especially hyperuricemia caused by excessive uric acid production; 2. Patients with recurrent or chronic gout; 3. Tophi; 4. Uric acid kidney stones and/or uric acid nephropathy; 5. Hyperuricemia with renal insufficiency.
Manufacturer:
Guangzhou Hanghe Pharmaceutical Company Limited
Allopurinol Tablets
Indication: 1. Primary and secondary hyperuricemia, especially hyperuricemia caused by excessive uric acid production; 2. Patients with recurrent or chronic gout; 3. Tophi; 4. Uric acid kidney stones and/or uric acid nephropathy; 5. Hyperuricemia with renal insufficiency.
Manufacturer:
Heifei Jiulian Pharma Co., Ltd.
Related Ingredients
-
Carvedilol list
72956-09-3 -
Erythropoietin list
11096-26-7 -
Allopurinol list
315-30-0